The Spanish biochemist Mariano Barbacid, who received the Honorary Award for Excellence in Scientific Trajectory granted by the AstraZeneca Foundation for his career as a researcher in the field of oncology, presented on July 25, the donation of this award, which represents an amount of 50,000 euros, to the CRIS Against Cancer Foundation, for the development of research projects for the treatment and cure of this disease. The excellent career of Dr. Mariano Barbacid was recognized with the Honorary Award in the VI Awards granted by the AstraZeneca Foundation.
This donation took place at an event held during the second meeting of the AstraZeneca Foundation Board of Trustees of which I have the pleasure of being a member, and was attended by Dr. Mariano Barbacid himself, Marta Cardona, Director of the CRIS Contra el Cáncer Foundation, Rick R. Suárez, President of the AstraZeneca Foundation and AstraZeneca Spain, and Marta Moreno, Vice President of the AstraZeneca Foundation and Director of Corporate Affairs and Market Access at AstraZeneca Spain. Dr. Barbacid said: “I firmly believe in supporting the fight against cancer through research and new advanced therapies. Therefore, I believe that the best way to advance towards the dreamed goal is to do it hand in hand with CRIS Contra el Cáncer and all the researchers that this Foundation supports and who give hope to so many families”. “The AstraZeneca Foundation is proud to know that the Honorary Award we are giving to Dr. Barbacid will enable the CRIS Contra el Cáncer Foundation to develop research projects,” said Rick R. Suárez, President of the AstraZeneca Foundation and AstraZeneca Spain.
For her part, Marta Moreno, Vice President of the AstraZeneca Foundation and Director of Corporate Affairs and Market Access at AstraZeneca Spain, said that “at the AstraZeneca Foundation we have been working tirelessly for more than two decades, connecting science with people and remaining true to our values, always committed to promoting research talent in our country”. Meanwhile, Marta Cardona, Director of the CRIS Against Cancer Foundation, recalled that “research is the only way to cure cancer, it is a disease that affects us all and the involvement of civil society is fundamental. The objective of the CRIS Against Cancer Foundation is to provide researchers with the necessary resources to work in the search for solutions to cure this disease”.
About AstraZeneca Foundation
The AstraZeneca Foundation is a non-profit organization created to support both healthcare professionals and researchers in their different fields, as well as to collaborate with public and private institutions and patient associations. All of this with the aim of bringing scientific knowledge closer to society and improving the quality of life of both patients and their environment.
About the CRIS Against Cancer Foundation
The CRIS Against Cancer Foundation aims to achieve effective treatments for cancer and does so by supporting, promoting and funding translational research against this disease. It is based in Spain, Great Britain and France. CRIS Against Cancer offers in its specialized CRIS Units, located in the main hospitals of the National Health System, pioneering therapies to patients for whom conventional therapies have failed.
It is undoubtedly an honor to be part of the patronage of such an important institution.
